IL6 and familial hypercholesterolemia: Shi et al. [24] found that the activation of leukocytes in the experimental model of diabetes and hypercholesterolemia is associated with a rapid increase in circulating Lp-PLA2 and an upregulation in a range of inflammatory mediators, including IL-6, TNF-α, and IL-1β.